Background: As rates of polypharmacy rise and medication regimens become more complex, the risk of potential cytochrome P450 (CYP)-mediated drug-drug interactions (DDIs) is a growing clinical concern for older adults.
Objective: To determine the prevalence of potential CYP-mediated DDIs in older hospitalized adults with polypharmacy and analyze the relationship between the number of drugs dispensed and the probability of these interactions in this high-risk population.
Methods: A prospective 16-week cohort study was conducted among consecutive new patients aged 65 years and older with polypharmacy (>5 drugs) admitted to a community hospital. The medication profiles of these patients were analyzed with a new multidrug cytochrome-specific software program. The prevalence of potential CYP-mediated DDIs was determined, with the probability calculated as a function of the number of medications dispensed using multivariate Poisson regression adjusted for age and sex. Comparative performance of the software program and a standard 2-drug alert program for detecting these DDIs was evaluated using the Wilcoxon-Mann-Whitney rank-sum test. Pharmacists' decisions to recommend medication adjustment based on the probability of CYP-mediated DDIs were recorded.
Results: The prevalence of potential CYP-mediated DDIs detected among 275 older adults with polypharmacy was 80%. The probability of at least 1 CYP-mediated DDI was 50% for persons taking 5-9 drugs, 81% with 10-14 drugs, 92% with 15-19 drugs, and 100% with 20 or more drugs. Addition of each medication to a 5-drug regimen conferred a 12% increased risk of a potential CYP-mediated DDI after adjustment for age and sex (OR 1.12; 95% CI 1.09-1.14). The multidrug software identified a median increase of 3 (95% CI 2.5-3.5) potential CYP-mediated DDIs per patient, compared to use of the standard 2-drug alert software. Pharmacists targeted patients for medication adjustment or close clinical monitoring in 23% of cases.
Conclusions: The prevalence of potential CYP-mediated DDIs is high in geriatric patients with polypharmacy. The risk of DDIs increases as a function of the number of medications dispensed. Pharmacists' decision to intervene for potential CYP-mediated DDIs depends on clinical judgment in addition to the output from drug alert software programs, but may be facilitated by a single multicomponent, multidrug potential CYP-mediated DDI assessment.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1345/aph.1R621 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genome-modified Caenorhabditis elegans expressing the human cytochrome P450 (CYP1A1 and CYP1A2) pathway: An experimental model for environmental carcinogenesis and pharmacological research.
Environ Int
December 2024
Department of Analytical, Environmental and Forensic Sciences, School of Cancer & Pharmaceutical Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. Electronic address:
Article Synopsis
- Polycyclic aromatic hydrocarbons (PAHs), like benzo[a]pyrene (BaP), arise from incomplete combustion and are found in sources like tobacco smoke and charbroiled food, posing cancer risks.
- Researchers genetically modified the nematode Caenorhabditis elegans to include human CYP1A1, CYP1A2, and epoxide hydrolase to study the effects of BaP exposure, observing changes in behavior and reproductive performance, such as increased pharyngeal pumping and decreased brood size.
- The findings revealed that the humanized worms experienced more severe reproductive toxicity and genetic mutations when exposed to BaP, highlighting the potential of these modified organisms for improving research practices while working towards the
Improved and Interpretable Prediction of Cytochrome P450-Mediated Metabolism by Molecule-Level Graph Modeling and Subgraph Information Bottlenecks.
J Chem Inf Model
December 2024
College of Metallurgy and Energy Engineering, Kunming University of Science and Technology, Kunming 650031, China.
Accurately identifying sites of metabolism (SoM) mediated by cytochrome P450 (CYP) enzymes, which are responsible for drug metabolism in the body, is critical in the early stage of drug discovery and development. Current computational methods for CYP-mediated SoM prediction face several challenges, including limitations to traditional machine learning models at the atomic level, heavy reliance on complex feature engineering, and the lack of interpretability relevant to medicinal chemistry. Here, we propose GraphCySoM, a novel molecule-level modeling approach based on graph neural networks, utilizing lightweight features and interpretable annotations on substructures, to effectively and interpretably predict CYP-mediated SoM.
View Article and Find Full Text PDFElucidating the metabolic roles of isoflavone synthase-mediated protein-protein interactions in yeast.
bioRxiv
October 2024
Robert F. Smith School of Chemical and Biomolecular Engineering, Cornell University, Ithaca, NY, 14853, USA.
Transient plant enzyme complexes formed via protein-protein interactions (PPIs) play crucial regulatory roles in secondary metabolism. Complexes assembled on cytochrome P450s (CYPs) are challenging to characterize metabolically due to difficulties in decoupling the PPIs' metabolic impacts from the CYPs' catalytic activities. Here, we developed a yeast-based synthetic biology approach to elucidate the metabolic roles of PPIs between a soybean-derived CYP, isoflavone synthase (GmIFS2), and other enzymes in isoflavonoid metabolism.
View Article and Find Full Text PDFDynamic interactions and inhibitory mechanisms of Artemisia annua terpenoids with carbonic anhydrase IX.
Int J Biol Macromol
December 2024
Departamento de Química, Módulo 13, Universidad Autónoma de Madrid, Campus de Excelencia UAM-CSIC Cantoblanco, 28049 Madrid, Spain; Institute for Advanced Research in Chemical Sciences (IAdChem), Universidad Autónoma de Madrid, 28049 Madrid, Spain. Electronic address:
This study evaluates the inhibitory potential of terpenoids isolated from Artemisia annua against carbonic anhydrase IX (CAIX), a crucial enzyme overexpressed in hypoxic tumor environments. Employing a multidisciplinary approach, we utilized in vitro assays, enzyme kinetics, molecular docking, and molecular dynamics (MD) simulations to comprehensively assess the efficacy of these compounds. Among the terpenoids tested, manool emerged as the most potent inhibitor, exhibiting the lowest IC value of 160.
View Article and Find Full Text PDFCharacterization and Expression of the Cytochrome P450 Genes in Exposed to Cerium Oxide Nanoparticles.
Int J Mol Sci
October 2024
Key Laboratory of Hydrobiology in Liaoning Province, Dalian Ocean University, Dalian 116021, China.
Article Synopsis
- Cerium oxide nanoparticles (nCeO) are increasingly entering aquatic ecosystems, raising health concerns for aquatic organisms due to their impact on detoxification processes mediated by Cytochrome P450 (CYP) enzymes.
- A genomic analysis identified 26 CYPs in the study organism, categorizing them into four clans and showing significant variation in protein size and weight, distributed across multiple chromosomes.
- The study found that exposure to nCeO significantly altered the expression levels of specific CYP genes, suggesting their important role in detoxifying metal nanoparticles and reinforcing the need for further research on their toxicological effects in aquatic invertebrates.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!